Apollo Global in Talks to Acquire Johnson & Johnson's Orthopedics Unit
Alternative asset manager Apollo Global Management Inc. is reportedly in discussions with Johnson & Johnson (J&J) about acquiring its orthopedics unit, DePuy Synthes. The potential deal could value the business at around $20 billion and may be finalized within weeks if talks continue successfully. J&J has been seeking to separate this division since last October as part of a broader strategy to streamline operations. DePuy Synthes generated $9.3 billion in sales last year, according to Bloomberg News, with estimates suggesting the unit could be valued at up to $28 billion including debt if sold. The orthopedics business is considered stable and would represent Apollo's largest investment yet in healthcare. J&J has also explored spinning off DePuy Synthes as a publicly traded company but remains on track for a mid-2027 separation regardless of the outcome.
Topics: Apollo Global DePuy Synthes Johnson & Johnson Orthopedics Unit